These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3292240)

  • 1. Hormonal and surgical treatment of endometrial adenocarcinoma.
    D'Addato F; Lanza A; Re A; Valli M; Raspollini M; Caldarola B; Allone T; Proserpio D; Ferraris G
    Eur J Gynaecol Oncol; 1988; 9(3):227-33. PubMed ID: 3292240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal and surgical treatment of endometrial adenocarcinoma: actuarial survival.
    Lanza A; D'Addato F; Re A; Zardo L; Vigezzi P; Raspollini M; Caldarola B; Rocca G; Proserpio D; Ferraris G
    Eur J Gynaecol Oncol; 1988; 9(3):209-15. PubMed ID: 3391193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New treatment procedure for stage I endometrial adenocarcinoma.
    Wolff JP; Pejovic MH; Michel G; Gerbaulet A; Prade M; George M
    Gynecol Oncol; 1986 Jan; 23(1):51-8. PubMed ID: 3943752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial adenocarcinoma: clinical outcome in 881 patients and analysis of 146 patients whose deaths were due to endometrial cancer.
    Tiitinen A; Forss M; Aho I; Vesterinen E; Nieminen U
    Gynecol Oncol; 1986 Sep; 25(1):11-9. PubMed ID: 3732910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 426 cases of stage I endometrial carcinoma: a clinicopathological analysis.
    Marziale P; Atlante G; Pozzi M; Diotallevi F; Iacovelli A
    Gynecol Oncol; 1989 Mar; 32(3):278-81. PubMed ID: 2920947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Stage I and II endometrial adenocarcinomas. Prognostic value of lymph node invasion].
    Descamps P; Calais G; Vitu L; Body G; Lansac J; Le Floch O
    J Gynecol Obstet Biol Reprod (Paris); 1991; 20(2):223-9. PubMed ID: 2071867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of quantitative analysis in the endometrial carcinoma.
    Aalto ML
    Eur J Obstet Gynecol Reprod Biol; 1988 Oct; 29(2):159-65. PubMed ID: 3056754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival in patients with paraaortic lymph node metastases from endometrial adenocarcinoma clinically limited to the uterus.
    Hicks ML; Piver MS; Puretz JL; Hempling RE; Baker TR; Mcauley M; Walsh DL
    Int J Radiat Oncol Biol Phys; 1993 Jul; 26(4):607-11. PubMed ID: 8330989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic significance of lymph-vascular space invasion in stage I endometrial cancer.
    Hanson MB; van Nagell JR; Powell DE; Donaldson ES; Gallion H; Merhige M; Pavlik EJ
    Cancer; 1985 Apr; 55(8):1753-7. PubMed ID: 3978563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hysteroscopy: its value in the pretherapeutic evaluation of endometrial adenocarcinomas].
    Martel P; Toufik L
    J Gynecol Obstet Biol Reprod (Paris); 1991; 20(2):216-20. PubMed ID: 2071866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metastatic mechanisms of uterine malignancies and therapeutic consequences].
    Lax SF; Tamussino KF; Lang PF
    Pathologe; 2016 Nov; 37(6):549-556. PubMed ID: 27757531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors in endometrial cancer.
    Rakar S; Kovacic J
    Eur J Gynaecol Oncol; 1990; 11(3):233-5. PubMed ID: 2209644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinico-pathological study and appraisal of treatment for endometrial cancer at the Ehime University Hospital].
    Iketani H; Itou T; Tomioka N; Hoashi J; Inohara T; Matsuura S
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Mar; 39(3):339-46. PubMed ID: 3559319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hormonal and surgical treatment of endometrial adenocarcinoma. Long-term follow-up. Results].
    D'Incerti Bonini L
    Minerva Ginecol; 1976; 28(7-8):630-8. PubMed ID: 1018851
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
    Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of myometrial invasion and tumor free distance from uterine serosa in endometrial cancer.
    Ozbilen O; Sakarya DK; Bezircioglu I; Kasap B; Yetimalar H; Yigit S
    Asian Pac J Cancer Prev; 2015; 16(2):519-22. PubMed ID: 25684481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometrial carcinoma, results of combined surgery and radiotherapy treatment of 93 patients (1979-1984).
    Snijders-Keilholz A; Stork M; Davelaar J; Hermans J; Leer JW
    Eur J Obstet Gynecol Reprod Biol; 1990; 36(1-2):125-35. PubMed ID: 2365118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Survival, prognostic factors and modern tendencies in adjuvant treatment of diagnosed endometrial cancer patients with or without lymph node dissection].
    Ivanov I
    Akush Ginekol (Sofiia); 2009; 48 Suppl 1():3-11. PubMed ID: 20387272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of stage II endometrial adenocarcinoma.
    Trimble EL; Jones HW
    Obstet Gynecol; 1988 Mar; 71(3 Pt 1):323-6. PubMed ID: 3347415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of combined radiation therapy and hormonal therapy in the management of lymph node-positive prostate cancer.
    Whittington R; Malkowicz SB; Machtay M; Van Arsdalen K; Barnes MM; Broderick GA; Wein AJ
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):673-80. PubMed ID: 9336149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.